Search details
1.
Association between event-free survival and overall survival in early-stage triple-negative breast cancer.
Future Oncol
; 20(6): 335-348, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37602372
2.
Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis.
J Cutan Med Surg
; 24(6): 561-572, 2020.
Article
in English
| MEDLINE | ID: mdl-32588642
3.
Cost-Effectiveness of Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Single-Agent Pembrolizumab for High-Risk Early-Stage Triple-Negative Breast Cancer in the United States.
Adv Ther
; 40(3): 1153-1170, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36648737
4.
Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models.
Pharmacoeconomics
; 40(3): 257-268, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34841472
5.
Budget impact of capmatinib for adults with metastatic non-small cell lung cancer harboring a MET exon 14 skipping mutation in the United States.
J Med Econ
; 24(1): 131-139, 2021.
Article
in English
| MEDLINE | ID: mdl-33397178
6.
A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany.
Int J Womens Health
; 11: 319-331, 2019.
Article
in English
| MEDLINE | ID: mdl-31191040
7.
Re: Ganz ML, Chavan A, Dhanda R, et al. Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia. J Med Econ. 2021;24(1):103-113.
J Med Econ
; 24(1): 835-836, 2021.
Article
in English
| MEDLINE | ID: mdl-34182864
8.
Cost-effectiveness of ranibizumab versus aflibercept in the treatment of visual impairment due to diabetic macular edema: a UK healthcare perspective.
Clinicoecon Outcomes Res
; 7: 235-47, 2015.
Article
in English
| MEDLINE | ID: mdl-25999748
Results
1 -
8
de 8
1
Next >
>>